Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims
Paul Langley · INNOVATIONS in Pharmacy · 2021
Abstract onlyNot checked
3 papersQuestions on this topic
Paul Langley · INNOVATIONS in Pharmacy · 2021
Abstract onlyNot checked
Paul Langley · INNOVATIONS in Pharmacy · 2019
Abstract onlyNot checked
Khaja Moinuddin, Deemah Sattam Alanazi, Bushra Abdulrahman Alsomali et al. · Journal of Pharmacy and Bioallied Sciences · 2021
Abstract onlyNot checked